Literature DB >> 2344507

Control of blood pressure in Scotland: the rule of halves.

W C Smith1, A J Lee, I K Crombie, H Tunstall-Pedoe.   

Abstract

OBJECTIVE: Audit of detection, treatment, and control of hypertension in adults in Scotland.
DESIGN: Cross sectional survey with random population sampling.
SETTING: General practice centres in 22 Scottish districts.
SUBJECTS: 5123 Men and 5236 women aged 40-59 in the Scottish heart health study, randomly selected from 22 districts throughout Scotland, of whom 1262 men and 1061 women had hypertension (defined as receiving antihypertensive treatment or with blood pressure above defined cut off points). MAIN OUTCOME MEASURE: Hypertension (assessed by standardised recording, questionnaire on diagnosis, and antihypertensive drug treatment) according to criteria of the World Health Organisation (receiving antihypertensive treatment or blood pressure greater than or equal to 160/95 mm Hg, or both) and to modified criteria of the British Hypertension Society.
RESULTS: In half the men with blood pressure greater than or equal to 160/95 mm Hg hypertension was undetected (670/1262, 53%), in half of those in whom it had been detected it was untreated (250/592, 42%), and in half of those receiving treatment it was not controlled (172/342, 50%). In women the numbers were: 486/1061, 46%; 188/575, 33%; and 155/387, 40% respectively. Assessment of blood pressure according to the British Hypertension Society's recommendations showed an improvement, but in only a quarter of men and 42% of women was hypertension detected and treated satisfactorily (142/561, 215/514 respectively). IMPLICATIONS: The detection and control of hypertension in Scotland is unsatisfactory, affecting management of this and other conditions, such as high blood cholesterol concentration, whose measurement is opportunistic and selective and depends on recognition of other risk factors.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2344507      PMCID: PMC1662684          DOI: 10.1136/bmj.300.6730.981

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  10 in total

Review 1.  The management of high blood pressure in general practice.

Authors:  J T Hart
Journal:  J R Coll Gen Pract       Date:  1975-03

Review 2.  Who is for cholesterol testing? Test selectively those who will benefit most.

Authors:  H Tunstall-Pedoe
Journal:  BMJ       Date:  1989-06-17

3.  Geographical variation in coronary heart disease mortality in Scotland.

Authors:  I K Crombie; W C Smith; M B Kenicer; H Tunstall-Pedoe
Journal:  Health Bull (Edinb)       Date:  1986-07

4.  The problem of undetected and untreated hypertension in the community.

Authors:  J A Wilber
Journal:  Bull N Y Acad Med       Date:  1973-06

5.  Hypertension--a community problem.

Authors:  J A Wilber; J G Barrow
Journal:  Am J Med       Date:  1972-05       Impact factor: 4.965

6.  The Scottish Heart Health Study: objectives and development of methods.

Authors:  W C Smith; I K Crombie; R Tavendale; J M Irving; M B Kenicer; H Tunstall Pedoe
Journal:  Health Bull (Edinb)       Date:  1987-07

7.  Blood pressure recording by general practitioners in north-east Scotland.

Authors:  L D Ritchie; A M Currie
Journal:  Br Med J (Clin Res Ed)       Date:  1983-01-08

8.  Influence of arm position on measurement of blood pressure.

Authors:  J Webster; D Newnham; J C Petrie; H G Lovell
Journal:  Br Med J (Clin Res Ed)       Date:  1984-05-26

9.  Detection and treatment of hypertension in an inner London community.

Authors:  R F Heller
Journal:  Br J Prev Soc Med       Date:  1976-12

10.  Detection and management of hypertension in general practices in north west London.

Authors:  K H Kurji; A P Haines
Journal:  Br Med J (Clin Res Ed)       Date:  1984-03-24
  10 in total
  47 in total

1.  Aiming at averages.

Authors:  E J Will
Journal:  J R Soc Med       Date:  2001-12       Impact factor: 5.344

Review 2.  Rule of halves: implications of increasing diagnosis and reducing dropout for future workload and prescribing costs in primary care.

Authors:  J T Hart
Journal:  Br J Gen Pract       Date:  1992-03       Impact factor: 5.386

Review 3.  The economics of shared care packages.

Authors:  S M McGhee; A J Hedley
Journal:  Pharmacoeconomics       Date:  1996-09       Impact factor: 4.981

4.  Prevalence, awareness, treatment, and control of hypertension: rule of thirds in the Skaraborg project.

Authors:  Ulf Lindblad; Johanna Ek; Jenny Eckner; Charlotte A Larsson; Guangliang Shan; Lennart Råstam
Journal:  Scand J Prim Health Care       Date:  2012-06       Impact factor: 2.581

Review 5.  [Medical clearance for missions abroad (EEU): definitions, recommendations for use and performance].

Authors:  Herwig Kollaritsch; Christoph Wenisch; Christoph Hatz; Gunther von Laer; Bernd Bauer; Ursula Hollenstein; Martin Haditsch; Gerhard Diridl; Waldemar Malinowski; Eva Jeschko; Gabriela Payer-Neundlinger; Nicole Speiser-Remp; Hannes E T Pichler; Helmut Rumpold; Heinrich Stemberger; Gerald Eder; Gerhard Wiedermann; Ursula Wiedermann
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

6.  An action plan for preventing coronary heart disease in primary care. Working Group of the Coronary Prevention Group and the British Heart Foundation.

Authors: 
Journal:  BMJ       Date:  1991-09-28

Review 7.  Prevalence of potentially inappropriate long term prescribing in general practice in the United Kingdom, 1980-95: systematic literature review.

Authors:  S A Buetow; B Sibbald; J A Cantrill; S Halliwell
Journal:  BMJ       Date:  1996-11-30

8.  Skin blood perfusion and cellular response to insertion of insulin pen needles with different diameters.

Authors:  Kezia Ann Præstmark; Casper Bo Jensen; Bente Stallknecht; Nils Berg Madsen; Jonas Kildegaard
Journal:  J Diabetes Sci Technol       Date:  2014-04-17

9.  GP documentation of obesity: what does it achieve?

Authors:  P Little
Journal:  Br J Gen Pract       Date:  1998-01       Impact factor: 5.386

10.  Hypertension in Ireland: public awareness and doctors choice of therapy.

Authors:  N L Zaharan; A Mahmud; K Bennett; J Feely
Journal:  Ir J Med Sci       Date:  2009-10-17       Impact factor: 1.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.